Key biomarker in obesity-related diabetes identified
Advertisement
Researchers have identified a new fingerprint of inflammation that may be able to predict which patients with obesity may also develop Type 2 diabetes.
The team from the Boston University School of Medicine (BUSM) quantified inflammatory proteins from blood immune system cells and combined the measurements mathematically to identify dominant inflammatory proteins.
Specifically, they identified Th17 cells, known to be involved in autoimmune diseases, as a dominant cell type in Type 2 diabetes.
The team from the Boston University School of Medicine (BUSM) quantified inflammatory proteins from blood immune system cells and combined the measurements mathematically to identify dominant inflammatory proteins.
Specifically, they identified Th17 cells, known to be involved in autoimmune diseases, as a dominant cell type in Type 2 diabetes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.